摘要:
The method of treating narcotic withdrawal symptoms in warm-blooded animals comprising administering to warm-blooded animals in need thereof an amount of a compound having anti-mineralocorticoid activity sufficient to treat narcotic withdrawal symptoms.
摘要:
Compounds having antimineralocorticoid activity suitable for preparing drugs for treating or preventing conditions related to drug dependence or to the spontaneous or induced withdrawal syndrome caused by narcotics or mixtures thereof, and compositions containing same, are disclosed.
摘要:
The invention relates to a novel therapeutic application of ketolides. The invention relates to the use of ketolides for the preparation of pharmaceutical compositions intended for preventing arterial thrombotic complications associated with atherosclerosis.
摘要:
The process for the preparation of an aldehyde of formula R--CHO in which R is an alkyl group of C.sub.1 -C.sub.7 comprises according to the invention the reaction on an alkyl formate of formula H--COOR in which R has the meaning given above, of a gas constituted mainly by CO, in the presence of(a) a catalyst based on a metal chosen from among Rh, Ru, Ir, mixtures of them or a mixture of Rh and/or Ru and/or Ir with Co, Ni or Fe,(b) a promoter chosen from among iodides and mixtures of covalent compounds of iodine and a phosphine or a tertiary amine,(c) a solvent consisting of a cyclic N-alkyl amide.
摘要:
Chiral phosphorus-containing ligands comprising at least one amine radical and at least one dihydrocarbylphosphinoxy radical of the formula W=OP (R).sub.2, in which R is a hydrocarbon radical selected from the group consisting of alkyl, aryl, and cycloalkyl radicals, wherein the ligand is selected from the group consisting of:those of the formula ##STR1## those of the formula ##STR2## those of the formula ##STR3## those of the formula ##STR4## in which formulae: R.sub.1 and R.sub.2 are selected from the group consisting of a hydrogen atom and hydrocarbon radicals;R.sub.3 and R.sub.4, which must be different from one another, are selected from the group consisting of a hydrogen atom and hydrocarbon radicals that may or may not carry at least one functional group selected from the group consisting of the alcohol, thiol, thioether, amine, imine, acid, ester, amide, and ether functional groups; andR.sub.5 and R.sub.6 are selected from the group consisting of hydrogen atoms and hydrocarbon radicals that may or may not contain functional groups.A process for their manufacture comprises reacting an optically active amino alcohol, in a hydrocarbon solvent at a temperature between -50.degree. and 80.degree. C. and under an inert gas atmosphere, with at least one compound of the formula P(R).sub.2 Y in which Y is chosen from among the halogen atoms and amine radicals, the compound being present in a molar ratio, relative to the amino alcohol, greater than or equal to the number of P(R).sub.2 groups to be introduced into the chiral molecule.The chiral phosphorous-containing ligands are used by reacting at least one organic compound that does not possess a center of asymmetry with (A), on the one hand, at least one transition metal complex of formula MZq in which M is a metal in group VIII of the Periodic Classification, q is the coordination number of the metal M, and Z is an atom or molecule capable of complexing the metal M and (B), on the other hand, at least one ligand L.
摘要:
The process according to the invention consists in dimerizing a conjugated diene in the presence of a catalyst obtained by bringing together (A) at least one nickel complex of formula NiZ.sub.q in which q is the coordination number of the nickel and Z is at least one ligand capable of complexing nickel and (B) at least one phosphorus-containing ligand of general formula ##STR1## in which: R.sub.1 is chosen from a hydrogen atom and hydrocarbon radicals,R.sub.2 and R.sub.3, which may be identical or different, are chosen from a hydrogen atom and hydrocarbon radicals optionally bearing at least one group chosen from alcohol, thiol, thioether, amine, imine, acid, ester, amide and ether groups, andm is greater than or equal to 1.
摘要:
Novel .alpha.-mercapto-alkylamines in all possible racemic, enantiomeric and diastereoisomeric forms of the formula ##STR1## wherein the substituents are as defined in the specification.
摘要:
The invention relates to a process for the preparation of acetic anhydride, characterized in that a gas containing essentially CO, at a pressure of at least 1 MPa, is reacted with methyl formate in the presence ofa) a rhodium-based catalyst,b) two iodine-containing promoters of different kind, successively ionic and covalent, andc) an N-substituted cyclic amide as solvent.
摘要:
The invention relates to platinum hydrides, a process for their preparation and their use as components of catalytic systems. The platinum hydrides have a bridged bimetallic structure represented by the general formula: ##STR1## wherein: M is a metal of valence n, at least equal to 2,X is a halogen atom, andP P is a schematic representation of a ligand of the general formula: ##STR2## in which: R.sub.1, R.sub.2, R.sub.5, and R.sub.6, identical or different, are chosen from among aliphatic or cycloaliphatic hydrocarbon radicals with 1 to 8 carbon atoms and aromatic hydrocarbon radicals with 6 to 10 carbon atoms,R.sub.3 and R.sub.4, identical or different, are chosen from among a hydrogen atom and aliphatic hydrocarbon radicals with 1 to 8 carbon atoms, possibly functionalized and/or together forming a ring, andm is an integer higher than or equal to 4.
摘要:
Novel .alpha.-mercaptomethyl-benzene propanamides of the formula ##STR1## wherein R.sub.1 is selected from the group consisting of hydrogen and ##STR2## R.sub.1 ' is selected from the group consisting of alkyl of 1 to 5 carbon atoms and aryl optionally substituted with at least one member of the group consisting of --OH, --NO.sub.2, halogen and alkyl and alkoxy of 1 to 5 carbon atoms, X and X' are individually selected from the group consisting of hydrogen, alkyl and alkoxy of 1 to 5 carbon atoms, --OH, halogen and --CF.sub.3, R.sub.2 is selected from the group consisting of pyrrolidinyl, morpholinyl, piperidinyl, piperazinyl, tetrahydrothiazinyl and hexahydroazepinyl, all optionally substituted with at least one member of the group consisting of alkyl and alkoxy of 1 to 5 carbon atoms, --OH, --NO.sub.2, --CF.sub.3, halogen and acyl of an organic carboxylic acid of 1 to 7 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts having analgesic activity, antidepression and anxiolytic properties.